Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 1:46 pm Purchase |
2021-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
FEDERATED HERMES INC. FHI |
6,914,136 7.530% |
6,914,136 (New Position) |
Filing History |
| 2022-02-14 06:05 am Sale |
2021-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
Nikko Asset Management Americas, Inc. | 785,519 0.860% |
-5,038,084 (-86.51%) |
Filing History |
| 2022-02-11 3:11 pm Purchase |
2021-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
JANUS HENDERSON GROUP PLC JHG |
5,055,099 5.500% |
5,055,099 (New Position) |
Filing History |
| 2022-02-10 08:37 am Purchase |
2021-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
The Vanguard Group | 4,676,265 5.090% |
4,676,265 (New Position) |
Filing History |
| 2022-02-09 10:24 am Purchase |
2022-02-08 | 13G | Seres Therapeutics, Inc. MCRB |
FMR CORP | 13,777,070 14.999% |
2,440,497 (+21.53%) |
Filing History |
| 2022-02-04 06:09 am Sale |
2021-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
Sumitomo Mitsui Trust Group, Inc. | 785,519 0.850% |
-5,038,084 (-86.51%) |
Filing History |
| 2022-02-03 4:41 pm Sale |
2021-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
BLACKROCK INC BLK |
5,862,691 6.400% |
-411,145 (-6.55%) |
Filing History |
| 2022-01-10 10:46 am Sale |
2021-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
STATE STREET CORP STT |
4,785,589 5.210% |
-5,217,802 (-52.16%) |
Filing History |
| 2021-10-12 12:39 pm Purchase |
2021-09-30 | 13G | Seres Therapeutics, Inc. MCRB |
STATE STREET CORP STT |
10,003,391 10.910% |
10,003,391 (New Position) |
Filing History |
| 2021-05-05 4:39 pm Purchase |
2021-04-27 | 13G | Seres Therapeutics, Inc. MCRB |
RA Capital Management, L.P. | 4,702,206 5.100% |
4,702,206 (New Position) |
Filing History |
| 2021-02-16 4:33 pm Purchase |
2020-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
ARK Investment Management LLC | 13,741,254 15.060% |
1,448,221 (+11.78%) |
Filing History |
| 2021-02-11 5:26 pm Purchase |
2020-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
Nikko Asset Management Americas, Inc. | 5,823,603 6.380% |
198,613 (+3.53%) |
Filing History |
| 2021-02-08 10:33 am Purchase |
2021-02-05 | 13G | Seres Therapeutics, Inc. MCRB |
FMR CORP | 11,336,573 12.423% |
536,073 (+4.96%) |
Filing History |
| 2021-02-05 06:10 am Purchase |
2020-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
Sumitomo Mitsui Trust Group, Inc. | 5,823,603 6.380% |
198,613 (+3.53%) |
Filing History |
| 2021-02-01 08:30 am Purchase |
2020-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
BLACKROCK INC BLK |
6,273,836 6.900% |
2,270,483 (+56.71%) |
Filing History |
| 2020-11-25 4:30 pm Sale |
2020-11-23 | 13D | Seres Therapeutics, Inc. MCRB |
Flagship VentureLabs IV LLC | 15,049,991 16.500% |
-6,596,914 (-30.48%) |
Filing History |
| 2020-10-09 2:17 pm Purchase |
2020-06-30 | 13G | Seres Therapeutics, Inc. MCRB |
ARK Investment Management LLC | 12,293,033 13.770% |
5,019,193 (+69.00%) |
Filing History |
| 2020-09-10 10:03 am Purchase |
2020-09-09 | 13G | Seres Therapeutics, Inc. MCRB |
FMR CORP | 10,800,500 12.095% |
4,301,382 (+66.18%) |
Filing History |
| 2020-09-09 06:03 am Sale |
2020-08-31 | 13G | Seres Therapeutics, Inc. MCRB |
Sumitomo Mitsui Trust Group, Inc. | 5,624,990 6.300% |
-2,648,233 (-32.01%) |
Filing History |
| 2020-09-08 1:28 pm Sale |
2020-08-31 | 13G | Seres Therapeutics, Inc. MCRB |
Nikko Asset Management Americas, Inc. | 5,624,990 6.300% |
-2,648,233 (-32.01%) |
Filing History |